ArticleCancer2018

Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?

Kiran Naqvi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.